Want to see HK:2211 full AI Analyst Report?
Top Page
Universal Health International Group Holding Ltd.
(2211)
Select Model
Select Model
Rating:42Neutral
Price Target:
HK$0.62
▼(-62.63% Downside)
Action:Reiterated
Date:07/31/26
The score is primarily held down by weak financial performance—shrinking revenue, recurring losses, and persistent negative operating/free cash flow—despite low leverage. Technicals offer only partial support (above shorter-term moving averages but still below the 200-day), while valuation is constrained by a negative P/E and no dividend data.
Positive Factors
Low leverage / balance-sheet flexibility
A very low debt-to-equity (~0.08) provides durable financial flexibility: it reduces near-term default risk, preserves borrowing capacity, and gives management time to execute recovery plans or raise capital without immediate solvency pressure, supporting viability over months.
Negative Factors
Shrinking revenue
A multi-year revenue decline (≈24% in FY2025 following FY2024 drops) is a structural headwind: it reduces scale, undermines pricing power, and prevents fixed-cost absorption. Without sustained top-line stabilization, margin gains won’t convert into durable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / balance-sheet flexibility
A very low debt-to-equity (~0.08) provides durable financial flexibility: it reduces near-term default risk, preserves borrowing capacity, and gives management time to execute recovery plans or raise capital without immediate solvency pressure, supporting viability over months.
Read all positive factors
Universal Health International Group Holding Ltd. (2211) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$72.41M
Dividend Yield1.84%
Average Volume (3M)8.93M
Price to Earnings (P/E)―
Beta (1Y)1.16
Revenue Growth-42.77%
EPS Growth-229.96%
CountryHK
Employees665
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)-0.28
Shares Outstanding110,546,220
10 Day Avg. Volume4,421,314
30 Day Avg. Volume8,934,653
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.27
Price to Sales (P/S)0.12
P/FCF Ratio-1.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Universal Health International Group Holding Ltd. Business Overview & Revenue Model
Company Description
Operating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern ...
How the Company Makes Money
null...
Universal Health International Group Holding Ltd. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
62
Positive
Cash Flow
22
Negative
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 537.18M | 711.51M | 1.09B | 1.30B | 1.27B | 1.19B |
| Gross Profit | 90.47M | 106.49M | 179.88M | 222.60M | 215.32M | 56.19M |
| EBITDA | -561.00K | -11.85M | 12.59M | -70.62M | -160.78M | -560.83M |
| Net Income | -24.05M | -26.01M | 413.00K | -105.40M | -187.65M | -675.40M |
Balance Sheet | ||||||
| Total Assets | 484.57M | 447.60M | 692.88M | 797.10M | 983.55M | 1.15B |
| Cash, Cash Equivalents and Short-Term Investments | 95.07M | 13.40M | 36.92M | 89.37M | 58.63M | 33.09M |
| Total Debt | 64.73M | 25.00M | 70.60M | 40.62M | 40.00M | 3.93M |
| Total Liabilities | 142.38M | 130.03M | 339.99M | 457.57M | 504.47M | 459.02M |
| Stockholders Equity | 342.19M | 317.57M | 352.72M | 314.73M | 408.13M | 574.97M |
Cash Flow | ||||||
| Free Cash Flow | -52.40M | -59.91M | -101.75M | -19.47M | -47.94M | -126.92M |
| Operating Cash Flow | -52.31M | -59.84M | -101.73M | -19.40M | -47.81M | -124.67M |
| Investing Cash Flow | 47.26M | 52.61M | 54.88M | -8.02M | 11.09M | 19.72M |
| Financing Cash Flow | 25.17M | -6.05M | 40.23M | 11.27M | 55.96M | -10.21M |
Universal Health International Group Holding Ltd. Technical Analysis
Positive
1.67
Price Trends
0.61
Positive
0.56
Positive
0.98
Negative
Market Momentum
<0.01
Positive
53.18
Neutral
69.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2211, the sentiment is Positive. The current price of 1.67 is above the 20-day moving average (MA) of 0.67, above the 50-day MA of 0.61, and above the 200-day MA of 0.98, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 53.18 is Neutral, neither overbought nor oversold. The STOCH value of 69.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2211.
Universal Health International Group Holding Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$320.38M | 9.78 | 4.28% | 8.25% | -2.78% | -24.77% | |
54 Neutral | HK$583.79M | 10.64 | 28.00% | ― | 91.32% | ― | |
54 Neutral | HK$469.86M | -145.50 | -0.41% | ― | 3.16% | -101.02% | |
53 Neutral | HK$1.23B | 84.76 | 0.48% | 1.02% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | HK$515.57M | -1.34 | -25.36% | 1.47% | -8.94% | -140.82% | |
42 Neutral | HK$72.41M | -2.06 | -7.29% | 1.84% | -42.77% | -229.96% |
* Healthcare Sector Average
HK:2211
Universal Health International Group Holding Ltd.
0.68
-0.82
-54.67%
HK:2138
EC Healthcare
0.46
-0.36
-44.51%
HK:2159
Mediwelcome Healthcare Management & Technology Inc.
1.72
0.22
14.67%
HK:3869
Hospital Corporation of China Ltd
3.40
-3.39
-49.93%
HK:3886
Town Health International Medical Group Ltd.
0.18
-0.09
-32.44%
HK:0722
UMP Healthcare Holdings Limited
0.40
-0.05
-11.50%
Universal Health International Group Holding Ltd. Corporate Events
Universal Health Revises Timetable for Capital Reorganisation and Rights Issue
Jul 31, 2026
Universal Health International Group Holding Ltd., a Cayman Islands-incorporated healthcare company listed on the Hong Kong Stock Exchange under stock code 2211, is pursuing a capital reorganisation and rights issue to reshape its equity base. The...
Universal Health Plans Capital Reorganisation and Major Rights Issue
Jul 17, 2026
Universal Health International Group Holding Ltd., a Cayman Islands‑incorporated healthcare company listed in Hong Kong, is reshaping its share capital to strengthen its balance sheet. The firm’s shares, traded under stock code 2211, p...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.